Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-01-04 @ 4:54 AM
Study NCT ID:
NCT05846568
Status:
COMPLETED
Last Update Posted:
2024-09-25
First Post:
2023-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate GR1801's Efficacy and Safety
Sponsor:
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-06
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-06
First Submit QC Date:
None
Study First Post Date:
2023-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-23
Last Update Post Date:
2024-09-25
Last Update Post Date Type:
ACTUAL